{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T11:42:04Z","timestamp":1726054924732},"publisher-location":"New York, NY","reference-count":16,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493998135"},{"type":"electronic","value":"9781493998142"}],"license":[{"start":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-1-4939-9814-2_6","type":"book-chapter","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T19:43:49Z","timestamp":1571168629000},"page":"111-130","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HSV-1 Amplicon Vectors as Genetic Vaccines"],"prefix":"10.1007","author":[{"given":"Anita F.","family":"Meier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea S.","family":"Laimbacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,16]]},"reference":[{"key":"6_CR1","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3390\/v1030594","volume":"1","author":"S Silva de","year":"2009","unstructured":"de Silva S, Bowers WJ (2009) Herpes virus amplicon vectors. Viruses 1:594\u2013629","journal-title":"Viruses"},{"key":"6_CR2","doi-asserted-by":"crossref","first-page":"44533","DOI":"10.18632\/oncotarget.17817","volume":"8","author":"F Caccuri","year":"2017","unstructured":"Caccuri F, Ronca R, Laimbacher AS et al (2017) U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis. Ocotarget 8:44533\u201344549","journal-title":"Ocotarget"},{"key":"6_CR3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1023\/A:1008022713466","volume":"30","author":"E Parrish","year":"1999","unstructured":"Parrish E, Peltekian E, Dickson G et al (1999) Cell engineering for muscle gene therapy: extemporaneous production of retroviral vector packaging macrophages using defective herpes simplex virus type 1 vectors harbouring gag, pol, env genes. Cytotechnology 30:173\u2013180","journal-title":"Cytotechnology"},{"key":"6_CR4","doi-asserted-by":"crossref","first-page":"10426","DOI":"10.1128\/JVI.73.12.10426-10439.1999","volume":"73","author":"M Sena-Esteves","year":"1999","unstructured":"Sena-Esteves M, Saeki Y, Camp SM et al (1999) Single-step conversion of cells to retrovirus vector producers with herpes simplex virus-Epstein-Barr virus hybrid amplicons. J Virol 73:10426\u201310439","journal-title":"J Virol"},{"key":"6_CR5","doi-asserted-by":"publisher","first-page":"7363","DOI":"10.1016\/j.vaccine.2010.09.011","volume":"28","author":"A D\u2019Antuono","year":"2010","unstructured":"D\u2019Antuono A, Laimbacher AS, La Torre J et al (2010) HSV-1 amplicon vectors that direct the in situ production of foot-and-mouth disease virus antigens in mammalian cells can be used for genetic immunization. Vaccine 28:7363\u20137372","journal-title":"Vaccine"},{"key":"6_CR6","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1038\/mt.2012.108","volume":"20","author":"AS Laimbacher","year":"2012","unstructured":"Laimbacher AS, Esteban LE, Castello AA et al (2012) HSV-1 amplicon vectors launch the production of heterologous rotavirus-like particles and induce rotavirus-specific immune responses in mice. Mol Ther 20:1810\u20131820","journal-title":"Mol Ther"},{"key":"6_CR7","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3390\/ijms18020431","volume":"18","author":"AF Meier","year":"2017","unstructured":"Meier AF, Suter M, Schraner EM et al (2017) Transfer of anti-rotavirus antibodies during pregnancy and in milk following maternal vaccination with a herpes simplex virus type-1 amplicon vector. Int J Mol Sci 18:431","journal-title":"Int J Mol Sci"},{"key":"6_CR8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.virol.2016.06.006","volume":"496","author":"TJ Taylor","year":"2016","unstructured":"Taylor TJ, Diaz F, Colgrove RC et al (2016) Production of immunogenic West Nile virus-like particles using a herpes simplex virus 1 recombinant vector. Virology 496:186\u2013193","journal-title":"Virology"},{"key":"6_CR9","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1006\/mthe.2001.0294","volume":"3","author":"Y Saeki","year":"2001","unstructured":"Saeki Y, Fraefel C, Ichikawa T et al (2001) Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome. Mol Ther 3:591\u2013601","journal-title":"Mol Ther"},{"key":"6_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/0042-6822(92)90062-T","volume":"186","author":"IL Smith","year":"1992","unstructured":"Smith IL, Hardwicke MA, Sandri-Goldin RM (1992) Evidence that the herpes simplex virus immediate early protein ICP27 acts post-transcriptionally during infection to regulate gene expression. Virology 186:74\u201386","journal-title":"Virology"},{"key":"6_CR11","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1089\/hum.1998.9.18-2787","volume":"9","author":"Y Saeki","year":"1998","unstructured":"Saeki Y, Ichikawa T, Saeki A et al (1998) Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors. Hum Gene Ther 9:2787\u20132794","journal-title":"Hum Gene Ther"},{"key":"6_CR12","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1099\/0022-1317-69-7-1531","volume":"69","author":"DJ McGeoch","year":"1988","unstructured":"McGeoch DJ, Dalrymple MA, Davison AJ et al (1988) The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol 69:1531\u20131574","journal-title":"J Gen Virol"},{"key":"6_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/978-1-4939-3008-1_13","volume-title":"Vaccine technologies for veterinary viral diseases","author":"AF Meier","year":"2016","unstructured":"Meier AF, Laimbacher AS, Ackermann M (2016) Polycistronic herpesvirus amplicon vectors for veterinary vaccine development. In: Brun A (ed) Vaccine technologies for veterinary viral diseases. Springer, New York, NY, pp 201\u2013224"},{"key":"6_CR14","doi-asserted-by":"crossref","first-page":"7851","DOI":"10.1128\/JVI.71.10.7851-7856.1997","volume":"71","author":"SE Coffin","year":"1997","unstructured":"Coffin SE, Moser CA, Cohen S et al (1997) Immunologic correlates of protection against rotavirus challenge after intramuscular immunization of mice. J Virol 71:7851\u20137856","journal-title":"J Virol"},{"key":"6_CR15","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1128\/JVI.64.10.5070-5075.1990","volume":"64","author":"RL Ward","year":"1990","unstructured":"Ward RL, McNeal MM, Sheridan JF (1990) Development of an adult mouse model for studies on protection against rotavirus. J Virol 64:5070\u20135075","journal-title":"J Virol"},{"key":"6_CR16","doi-asserted-by":"publisher","DOI":"10.1385\/1592590780","volume-title":"Rotaviruses: methods and protocols","author":"J Gray","year":"2000","unstructured":"Gray J, Desselberger U (2000) Rotaviruses: methods and protocols. Humana, New York"}],"container-title":["Methods in Molecular Biology","Herpes Simplex Virus"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-9814-2_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T22:14:07Z","timestamp":1611526447000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-9814-2_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,16]]},"ISBN":["9781493998135","9781493998142"],"references-count":16,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-9814-2_6","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2019,10,16]]},"assertion":[{"value":"16 October 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}